<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02771990</url>
  </required_header>
  <id_info>
    <org_study_id>2013-042</org_study_id>
    <nct_id>NCT02771990</nct_id>
  </id_info>
  <brief_title>tDCS for Chronic Low Back Pain</brief_title>
  <official_title>tDCS for Chronic Low Back Pain: A Study Examining the Effect of Transcranial Direct Current Stimulation on the Emotional Response to Chronic Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Providence VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Providence VA Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to investigate the role of central neural pathways in mediating&#xD;
      chronic pain. The aim of the study is to test the effect of stimulating brain regions that&#xD;
      are part of a network underlying central pain processing using a non-invasive brain&#xD;
      stimulation technique, transcranial Direct Current Stimulation (tDCS). Prior studies have&#xD;
      used tDCS to target both sensory related cortical areas and those important for higher-order&#xD;
      representations of pain. This study will target brain regions important for the behavioral&#xD;
      response to the chronic sensation of pain. The hypothesis is that stimulation of these brain&#xD;
      regions can modulate not only the affective component of pain, but ultimately also improve&#xD;
      functioning and quality of life. This hypothesis will be tested by treating study&#xD;
      participants eighteen and older with chronic low back pain (CLBP) of greater than six months&#xD;
      using tDCS. To be part of this study, participants must meet all the inclusion and exclusion&#xD;
      criteria.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">April 3, 2018</completion_date>
  <primary_completion_date type="Actual">April 3, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>West Haven-Yale Multidimensional Pain Inventory (WHY-MPI) General Activity Subscale Rating</measure>
    <time_frame>8 weeks</time_frame>
    <description>The WHY-MPI General Activity subscale contains 18 items summed to give a score ranging from 0 to 108 (higher scores indicate more activity [better]).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Anxiety Symptom Scale (PASS-20) Rating</measure>
    <time_frame>8 weeks</time_frame>
    <description>The PASS-20 contains 20 items and scores could range from 0 to 100 (higher scores indicate greater pain anxiety).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>10 sessions sham transcranial direct current stimulation (tDCS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>active tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 sessions active transcranial direct current stimulation (tDCS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham transcranial direct current stimulation</intervention_name>
    <description>sham stimulation</description>
    <arm_group_label>sham tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation</intervention_name>
    <description>2 milliamp (mA) 20 minutes</description>
    <arm_group_label>active tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic Low Back Pain â‰¥ 6 months duration in the lumbar region, present more than half&#xD;
             the days of the month, and on average be at a moderate level of severity in the last&#xD;
             month&#xD;
&#xD;
          -  At least one trial of physician recommended medication (e.g. acetaminophen, NSAIDS,&#xD;
             skeletal muscle relaxants)&#xD;
&#xD;
          -  Pre-existing opioid and non-opioid pain medication must be non-existent or stable&#xD;
             (medications have not changed for one month)&#xD;
&#xD;
          -  Be able to understand, read and write English&#xD;
&#xD;
          -  If female and of childbearing age, agree to use acceptable birth control during the&#xD;
             study treatment period (oral contraceptives, history of tubal ligation, history of a&#xD;
             hysterectomy, or a reliable barrier method)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lifetime Diagnostic and Statistical Manual (DSM) IV diagnosis of bipolar disorder,&#xD;
             schizophrenia, or other chronic psychotic condition&#xD;
&#xD;
          -  Current DSM-IV diagnosis of substance dependence for alcohol, sedative/hypnotic drugs,&#xD;
             stimulants, cocaine&#xD;
&#xD;
          -  Current cancer, infection, or inflammatory arthritis&#xD;
&#xD;
          -  Broken skin or other lesions in the area of the electrodes&#xD;
&#xD;
          -  Uncontrolled medical problems, such as diabetes mellitus, hypertension, pulmonary or&#xD;
             airway disease, heart failure, coronary artery disease, or any other condition that&#xD;
             poses a risk for the subject during participation&#xD;
&#xD;
          -  Presence of metal in the cranial cavity&#xD;
&#xD;
          -  Holes in the skull made by trauma or surgery&#xD;
&#xD;
          -  Pacemakers, medication pumps, and other implanted electronic hardware&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frederick Burgess, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence VA Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Benjamin Greenberg, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence VA Medical Center</affiliation>
  </overall_official>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>May 12, 2016</study_first_submitted>
  <study_first_submitted_qc>May 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2016</study_first_posted>
  <results_first_submitted>October 10, 2019</results_first_submitted>
  <results_first_submitted_qc>April 9, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 4, 2021</results_first_posted>
  <last_update_submitted>April 9, 2021</last_update_submitted>
  <last_update_submitted_qc>April 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Providence VA Medical Center</investigator_affiliation>
    <investigator_full_name>Benjamin Greenberg</investigator_full_name>
    <investigator_title>Associate Director, CfNN</investigator_title>
  </responsible_party>
  <keyword>Back Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Only de-identified data will be shared.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 19, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/90/NCT02771990/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of the 30 participants that were consented, 9 participants were ineligible, withdrew, or were lost to contact before commencing tDCS.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Sham tDCS</title>
          <description>10 sessions sham transcranial direct current stimulation (tDCS)&#xD;
Sham transcranial direct current stimulation: sham stimulation</description>
        </group>
        <group group_id="P2">
          <title>Active tDCS</title>
          <description>10 sessions active transcranial direct current stimulation (tDCS)&#xD;
transcranial direct current stimulation: 2 milliamp (mA) 20 minutes</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sham tDCS</title>
          <description>10 sessions sham transcranial direct current stimulation (tDCS)&#xD;
Sham transcranial direct current stimulation: sham stimulation</description>
        </group>
        <group group_id="B2">
          <title>Active tDCS</title>
          <description>10 sessions active transcranial direct current stimulation (tDCS)&#xD;
transcranial direct current stimulation: 2 milliamp (mA) 20 minutes</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.7" spread="1.8"/>
                    <measurement group_id="B2" value="65.7" spread="8.8"/>
                    <measurement group_id="B3" value="63.1" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Years of Education</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.7" spread="2.6"/>
                    <measurement group_id="B2" value="14.0" spread="2.6"/>
                    <measurement group_id="B3" value="14.4" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>West Haven-Yale Multidimensional Pain Inventory (WHY-MPI) General Activity Subscale Rating</title>
        <description>The WHY-MPI General Activity subscale contains 18 items summed to give a score ranging from 0 to 108 (higher scores indicate more activity [better]).</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham tDCS</title>
            <description>10 sessions sham transcranial direct current stimulation (tDCS)&#xD;
Sham transcranial direct current stimulation: sham</description>
          </group>
          <group group_id="O2">
            <title>Active tDCS</title>
            <description>10 sessions active transcranial direct current stimulation (tDCS)&#xD;
transcranial direct current stimulation: 2 milliamp (mA) 20 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>West Haven-Yale Multidimensional Pain Inventory (WHY-MPI) General Activity Subscale Rating</title>
          <description>The WHY-MPI General Activity subscale contains 18 items summed to give a score ranging from 0 to 108 (higher scores indicate more activity [better]).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.3" spread="17.7"/>
                    <measurement group_id="O2" value="48.4" spread="21.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Pilot study</non_inferiority_desc>
            <p_value>0.002</p_value>
            <method>Regression, Linear</method>
            <param_type>z-score</param_type>
            <param_value>3.11</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Anxiety Symptom Scale (PASS-20) Rating</title>
        <description>The PASS-20 contains 20 items and scores could range from 0 to 100 (higher scores indicate greater pain anxiety).</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham tDCS</title>
            <description>10 sessions sham transcranial direct current stimulation (tDCS)&#xD;
Sham transcranial direct current stimulation: sham</description>
          </group>
          <group group_id="O2">
            <title>Active tDCS</title>
            <description>10 sessions active transcranial direct current stimulation (tDCS)&#xD;
transcranial direct current stimulation: 2 milliamp (mA) 20 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Anxiety Symptom Scale (PASS-20) Rating</title>
          <description>The PASS-20 contains 20 items and scores could range from 0 to 100 (higher scores indicate greater pain anxiety).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.4" spread="22.0"/>
                    <measurement group_id="O2" value="26.3" spread="23.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Pilot study</non_inferiority_desc>
            <p_value>0.67</p_value>
            <method>Regression, Linear</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>8 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Sham tDCS</title>
          <description>10 sessions sham transcranial direct current stimulation (tDCS)&#xD;
Sham transcranial direct current stimulation: sham stimultion</description>
        </group>
        <group group_id="E2">
          <title>Active tDCS</title>
          <description>10 sessions active transcranial direct current stimulation (tDCS)&#xD;
transcranial direct current stimulation: 2 milliamp (mA) 20 minutes</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>small sample size (N = 21), participants were not stratified by premorbid anxiety levels, inability to guarantee optimal targeting of the left dorsal anterior cingulate cortex, inability to address laterality effects of pain perception</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Benjamin Greenberg</name_or_title>
      <organization>Providence Veterans Affairs Medical Center</organization>
      <phone>4012737100</phone>
      <email>benjamin.greenberg@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

